<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37063869</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Application of weighted gene co-expression network and immune infiltration for explorations of key genes in the brain of elderly COVID-19 patients.</ArticleTitle><Pagination><StartPage>1157179</StartPage><MedlinePgn>1157179</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1157179</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1157179</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Although many studies have demonstrated the existing neurological symptoms in COVID-19 patients, the mechanisms are not clear until now. This study aimed to figure out the critical molecular and immune infiltration situations in the brain of elderly COVID-19 patients.</AbstractText><AbstractText Label="METHODS">GSE188847 was used for the differential analysis, WGCNA, and immune infiltration analysis. We also performed GO, KEGG, GSEA, and GSVA for the enrich analysis.</AbstractText><AbstractText Label="RESULTS">266 DEGs, obtained from the brain samples of COVID-19 and non-COVID-19 patients whose ages were over 70 years old, were identified. GO and KEGG analysis revealed the enrichment in synapse and neuroactive ligand-receptor interaction in COVID-19 patients. Further analysis found that asthma and immune system signal pathways were significant changes based on GSEA and GSVA. Immune infiltration analysis demonstrated the imbalance of CD8+ T cells, neutrophils, and HLA. The MEpurple module genes were the most significantly different relative to COVID-19. Finally, RPS29, S100A10, and TIMP1 were the critical genes attributed to the progress of brain damage.</AbstractText><AbstractText Label="CONCLUSION">RPS29, S100A10, and TIMP1 were the critical genes in the brain pathology of COVID-19 in elderly patients. Our research has revealed a new mechanism and a potential therapeutic target.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Huang, Qin, Guo, Li, Li and Wang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Lixia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine, Jianghan University, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tianyuan Translational Medicine R&amp;D Team, School of Medicine, Jianghan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine, Jianghan University, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Jianghan University, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institution of Pulmonary Vascular Disease, Jianghan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Zirui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Materials (D-MATL), ETH Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine, Jianghan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Fajiu</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Jianghan University, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institution of Pulmonary Vascular Disease, Jianghan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Tianyuan Translational Medicine R&amp;D Team, School of Medicine, Jianghan University, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Histology and Embryology, School of Medicine, Jianghan University, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005809" MajorTopicYN="N">Genes, Regulator</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001930" MajorTopicYN="Y">Brain Injuries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">RPS 29</Keyword><Keyword MajorTopicYN="N">S100A10</Keyword><Keyword MajorTopicYN="N">TIMP 1</Keyword><Keyword MajorTopicYN="N">brain damage</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">lung-brain axis</Keyword><Keyword MajorTopicYN="N">sequelae</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>10</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>3</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37063869</ArticleId><ArticleId IdType="pmc">PMC10102454</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1157179</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Health Organization . Coronavirus disease (COVID-19) pandemic [EB/OL]. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019). (Accessed January 01, 2023).</Citation></Reference><Reference><Citation>Petersen EL, Gossling A, Adam G, Aepfelbacher M, Behrendt CA, Cavus E, et al. . Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg city health study COVID programme. Eur Heart J (2022) 43(11):1124&#x2013;37. doi:&#xa0;10.1093/eurheartj/ehab914</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab914</ArticleId><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberecker M, Schwarz EI, Steiger P, Frontzek K, Scholkmann F, Zeng X, et al. . Autopsy-based pulmonary and vascular pathology: Pulmonary endotheliitis and multi-organ involvement in COVID-19 associated deaths. Respiration (2022) 101(2):155&#x2013;65. doi:&#xa0;10.1159/000518914</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518914</ArticleId><ArticleId IdType="pmc">PMC8678227</ArticleId><ArticleId IdType="pubmed">34525475</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, Luscher TF, Neubauer S. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J (2022) 43(11):1157&#x2013;72. doi:&#xa0;10.1093/eurheartj/ehac031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol (2022) 23(2):194&#x2013;202. doi:&#xa0;10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) (2021) 53(10):737&#x2013;54. doi:&#xa0;10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hingorani KS, Bhadola S, Cervantes-Arslanian AM. COVID-19 and the brain. Trends Cardiovasc Med (2022) 32(6):323&#x2013;30. doi:&#xa0;10.1016/j.tcm.2022.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2022.04.004</ArticleId><ArticleId IdType="pmc">PMC9022395</ArticleId><ArticleId IdType="pubmed">35461991</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrikaki M, Lee JD, Solomon IH, Slack. FJ. Severe COVID-19 is associated with molecular signatures of aging in the human brain. Nat Aging (2022) 2:1130&#x2013;7. doi:&#xa0;10.1038/s43587-022-00321-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00321-w</ArticleId><ArticleId IdType="pubmed">37118539</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: A systematic review and meta-analysis. Otolaryngol Head Neck Surg (2020) 163(1):3&#x2013;11. doi:&#xa0;10.1177/0194599820926473</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820926473</ArticleId><ArticleId IdType="pubmed">32369429</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, et al. . SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature (2022) 612(7941):758&#x2013;63. doi:&#xa0;10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA (2020) 324(8):782&#x2013;93. doi:&#xa0;10.1001/jama.2020.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J, Coupland CA, Mehta N, Keogh RH, Diaz-Ordaz K, Khunti K, et al. . Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study. BMJ (2021) 374:n2244. doi:&#xa0;10.1136/bmj.n2244.Citedin:Pubmed</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2244.Citedin:Pubmed</ArticleId><ArticleId IdType="pmc">PMC8446717</ArticleId><ArticleId IdType="pubmed">34535466</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors (2021) 47(2):232&#x2013;41. doi:&#xa0;10.1002/biof.1726</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1726</ArticleId><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V, Winkler F. Cognitive deficits in long COVID-19. N Engl J Med (2022) 387(19):1813&#x2013;5. doi:&#xa0;10.1056/NEJMcibr2210069</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2210069</ArticleId><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol (2017) 13(1):25&#x2013;36. doi:&#xa0;10.1038/nrneurol.2016.187</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.187</ArticleId><ArticleId IdType="pubmed">27934854</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelgrim CE, Wang L, Peralta Marzal LN, Korver S, van Ark I, Leusink-Muis T, et al. . Increased exploration and hyperlocomotion in a cigarette smoke and LPS-induced murine model of COPD: linking pulmonary and systemic inflammation with the brain. Am J Physiol Lung Cell Mol Physiol (2022) 323(3):L251&#x2013;65. doi:&#xa0;10.1152/ajplung.00485.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00485.2021</ArticleId><ArticleId IdType="pubmed">35699308</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell (2021) 184(4):861&#x2013;80. doi:&#xa0;10.1016/j.cell.2021.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7803150</ArticleId><ArticleId IdType="pubmed">33497610</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavasolian F, Rashidi M, Hatam GR, Jeddi M, Hosseini AZ, Mosawi SH, et al. . HLA, immune response, and susceptibility to COVID-19. Front Immunol (2020) 11:601886. doi:&#xa0;10.3389/fimmu.2020.601886</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.601886</ArticleId><ArticleId IdType="pmc">PMC7820778</ArticleId><ArticleId IdType="pubmed">33488597</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond MS, Kanneganti TD. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol (2022) 23(2):165&#x2013;76. doi:&#xa0;10.1038/s41590-021-01091-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01091-0</ArticleId><ArticleId IdType="pmc">PMC8935980</ArticleId><ArticleId IdType="pubmed">35105981</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva SJR, Alves da Silva CT, Mendes RPG, Pena L. Role of nonstructural proteins in the pathogenesis of SARS-CoV-2. J Med Virol (2020) 92(9):1427&#x2013;9. doi:&#xa0;10.1002/jmv.25858</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25858</ArticleId><ArticleId IdType="pmc">PMC7262198</ArticleId><ArticleId IdType="pubmed">32270884</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamitani W, Huang C, Narayanan K, Lokugamage KG, Makino S. A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein. Nat Struct Mol Biol (2009) 16(11):1134&#x2013;40. doi:&#xa0;10.1038/nsmb.1680</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1680</ArticleId><ArticleId IdType="pmc">PMC2784181</ArticleId><ArticleId IdType="pubmed">19838190</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T, Kamitani W, DeDiego ML, Enjuanes L, Matsuura Y. Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA. J Virol (2012) 86(20):11128&#x2013;37. doi:&#xa0;10.1128/JVI.01700-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01700-12</ArticleId><ArticleId IdType="pmc">PMC3457165</ArticleId><ArticleId IdType="pubmed">22855488</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee AK, Blanco MR, Bruce EA, Honson DD, Chen LM, Chow A, et al. . SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell (2020) 183(5):1325&#x2013;1339.e21. doi:&#xa0;10.1016/j.cell.2020.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7543886</ArticleId><ArticleId IdType="pubmed">33080218</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri-Hosseinabadi Z, Abbasi M, Kahnooji M, Ghorbani Z, Abbasifard M. The prognostic value of S100A calcium binding protein family members in predicting severe forms of COVID-19. Inflamm Res (2022) 71(3):369&#x2013;76. doi:&#xa0;10.1007/s00011-022-01545-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-022-01545-7</ArticleId><ArticleId IdType="pmc">PMC8881187</ArticleId><ArticleId IdType="pubmed">35217896</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Al-Tamimi AO, Halwani R, Alsaidi H, Kannan M, Ahmad F. Lipocalin-2, S100A8/A9, and cystatin c: Potential predictive biomarkers of cardiovascular complications in COVID-19. Exp Biol Med (Maywood) (2022) 247(14):1205&#x2013;13. doi:&#xa0;10.1177/15353702221091990</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15353702221091990</ArticleId><ArticleId IdType="pmc">PMC9379606</ArticleId><ArticleId IdType="pubmed">35466734</ArticleId></ArticleIdList></Reference><Reference><Citation>Brusa S, Terracciano D, Bruzzese D, Fiorenza M, Stanziola L, Pinchera B, et al. . Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status. Front Med (Lausanne) (2022) 9:1034288. doi:&#xa0;10.3389/fmed.2022.1034288</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1034288</ArticleId><ArticleId IdType="pmc">PMC9744795</ArticleId><ArticleId IdType="pubmed">36523781</ArticleId></ArticleIdList></Reference><Reference><Citation>Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, Barrios R, et al. . TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. a prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol (2000) 279(3):L562&#x2013;74. doi:&#xa0;10.1152/ajplung.2000.279.3.L562</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.2000.279.3.L562</ArticleId><ArticleId IdType="pubmed">10956632</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H, Yang X, Yan M, Fang X, Wang Y, Qi H, et al. . Correlation of serum m-CSF, CER, and TIMP-1 levels with liver fibrosis in viral hepatitis. Comput Math Methods Med (2022) 2022:6736225. doi:&#xa0;10.1155/2022/6736225</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/6736225</ArticleId><ArticleId IdType="pmc">PMC9553341</ArticleId><ArticleId IdType="pubmed">36238481</ArticleId></ArticleIdList></Reference><Reference><Citation>Busk TM, Bendtsen F, Nielsen HJ, Jensen V, Brunner N, Moller S. TIMP-1 in patients with cirrhosis: relation to liver dysfunction, portal hypertension, and hemodynamic changes. Scand J Gastroenterol (2014) 49(9):1103&#x2013;10. doi:&#xa0;10.3109/00365521.2014.934910</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365521.2014.934910</ArticleId><ArticleId IdType="pubmed">25048331</ArticleId></ArticleIdList></Reference><Reference><Citation>Lose F, Thompson PJ, Duffy D, Stewart GA, Kedda MA. A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women. Thorax (2005) 60(8):623&#x2013;8. doi:&#xa0;10.1136/thx.2004.026930</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2004.026930</ArticleId><ArticleId IdType="pmc">PMC1747496</ArticleId><ArticleId IdType="pubmed">16061701</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SR. TIMP-1 in asthma: Guilty by association. Thorax (2005) 60(8):617&#x2013;8. doi:&#xa0;10.1136/thx.2004.036475</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2004.036475</ArticleId><ArticleId IdType="pmc">PMC1747477</ArticleId><ArticleId IdType="pubmed">16061698</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta S, Addya S, Biswas D, Banerjee P, Sarma JD. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in murine beta-coronavirus-induced neuroinflammation. Virology (2022) 566:122&#x2013;35. doi:&#xa0;10.1016/j.virol.2021.11.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2021.11.012</ArticleId><ArticleId IdType="pmc">PMC8648396</ArticleId><ArticleId IdType="pubmed">34906793</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Zhang S, Zhang A, Yan G, Wu X, Han Y, et al. . Metabolomic analysis of diet-induced type 2 diabetes using UPLC/MS integrated with pattern recognition approach. PloS One (2014) 9(3):e93384. doi:&#xa0;10.1371/journal.pone.0093384</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093384</ArticleId><ArticleId IdType="pmc">PMC3966886</ArticleId><ArticleId IdType="pubmed">24671089</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona G, Pizzocaro A, Vena W, Rastrelli G, Semeraro F, Isidori AM, et al. . Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis. Rev Endocr Metab Disord (2021) 22(2):275&#x2013;96. doi:&#xa0;10.1007/s11154-021-09630-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09630-8</ArticleId><ArticleId IdType="pmc">PMC7899074</ArticleId><ArticleId IdType="pubmed">33616801</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>